MAJER; PAVEL
Patent Applications and Registrations
Patent applications and USPTO patent grants for MAJER; PAVEL.The latest application filed is for "method of preparing a don prodrug from l-pyroglutamic acid".
Company Profile
15.21.27
- MAJER; PAVEL - SYKESVILLE MD
- Majer; Pavel - Prague CZ
- MAJER; Pavel - Praha 4 CZ
- Majer; Pavel - Frederick MD
Patent Activity
| Patent | Date |
|---|---|
| Method Of Preparing A Don Prodrug From L-pyroglutamic Acid App 20220194898 - LAWSON; JON PHILIP ; et al. | 2022-06-23 |
| Prodrugs of prostate specific membrane antigen (PSMA) inhibitor Grant 11,325,931 - Slusher , et al. May 10, 2 | 2022-05-10 |
| Method Of Preparing A Don Prodrug From L-glutamic Acid App 20220089522 - LAWSON; JON PHILIP ; et al. | 2022-03-24 |
| Prodrugs of glutamine analogs Grant 11,185,534 - Slusher , et al. November 30, 2 | 2021-11-30 |
| Prodrugs Of Hydroxamate-based Gcpii Inhibitors App 20210355079 - Slusher; Barbara ; et al. | 2021-11-18 |
| Prodrug compositions and utility of hydroxamate-based GCPII inhibitors Grant 11,059,775 - Slusher , et al. July 13, 2 | 2021-07-13 |
| Mebendazole Prodrugs With Enhanced Solubility And Oral Bioavailability App 20210205271 - Slusher; Barbara ; et al. | 2021-07-08 |
| Prodrugs Of Glutamine Analogs App 20210206787 - SLUSHER; Barbara ; et al. | 2021-07-08 |
| Methods for Cancer and Immunotherapy Using Prodrugs of Glutamine Analogs App 20210145779 - SLUSHER; Barbara ; et al. | 2021-05-20 |
| Prodrugs of glutamine analogs Grant 10,954,257 - Slusher , et al. March 23, 2 | 2021-03-23 |
| Peptidyl ketoamides as inhibitors of rhomboid proteases Grant 10,927,146 - Strisovsky , et al. February 23, 2 | 2021-02-23 |
| Prodrugs Of Prostate Specific Membrane Antigen (psma) Inhibitor App 20200399298 - SLUSHER; BARBARA ; et al. | 2020-12-24 |
| Methods for cancer and immunotherapy using prodrugs of glutamine analogs Grant 10,842,763 - Slusher , et al. November 24, 2 | 2020-11-24 |
| Prodrugs of glutamine analogs Grant 10,738,066 - Slusher , et al. A | 2020-08-11 |
| Prodrugs Of Glutamine Analogs App 20200230111 - Slusher; Barbara ; et al. | 2020-07-23 |
| Method of detection of analyte active forms and determination of the ability of substances to bind into analyte active sites Grant 10,718,772 - Navratil , et al. | 2020-07-21 |
| Peptidyl Ketoamides As Inhibitors Of Rohomboid Proteases App 20200095278 - STRISOVSKY; Kvido ; et al. | 2020-03-26 |
| Prodrugs of prostate specific membrane antigen (PSMA) inhibitor Grant 10,544,176 - Slusher , et al. Ja | 2020-01-28 |
| Novel Prodrug Compositions And Utility Of Hydroxamate-based Gcpii Inhibitors App 20190352255 - Slusher; Barbara ; et al. | 2019-11-21 |
| Prodrugs Of Glutamine Analogs App 20190315784 - Slusher; Barbara ; et al. | 2019-10-17 |
| Prodrugs Of Glutamine Analogs App 20190315783 - Slusher; Barbara ; et al. | 2019-10-17 |
| Prodrugs of glutamine analogs Grant 10,336,778 - Slusher , et al. | 2019-07-02 |
| Macromolecular conjugates for visualization and separation of proteins and cells Grant 10,302,632 - Sacha , et al. | 2019-05-28 |
| Macromolecular Conjugates For Visualization And Separation Of Proteins And Cells App 20190033300 - SACHA; PAVEL ; et al. | 2019-01-31 |
| Prodrugs Of Prostate Specific Membrane Antigen (psma) Inhibitor App 20180244705 - SLUSHER; BARBARA ; et al. | 2018-08-30 |
| Prodrugs Of Glutamine Analogs App 20180222930 - Slusher; Barbara ; et al. | 2018-08-09 |
| Prodrugs of prostate specific membrane antigen (PSMA) inhibitor Grant 9,988,407 - Slusher , et al. June 5, 2 | 2018-06-05 |
| Macromolecular Conjugates For Visualization And Separation Of Proteins And Cells App 20180052152 - Sacha; Pavel ; et al. | 2018-02-22 |
| Prodrugs Of Prostate Specific Membrane Antigen (psma) Inhibitor App 20170226141 - SLUSHER; Barbara ; et al. | 2017-08-10 |
| Method Of Detection Of Analyte Active Forms And Determination Of The Ability Of Substances To Bind Into Analyte Active Sites App 20170219583 - NAVRATIL; Vaclav ; et al. | 2017-08-03 |
| Bimacrocylic HCV NS3 protease inhibitors Grant 8,703,700 - Majer , et al. April 22, 2 | 2014-04-22 |
| Bimacrocylic HCV NS3 Protease Inhibitors App 20120141414 - Majer; Pavel ; et al. | 2012-06-07 |
| Indoles as NAALADase inhibitors Grant 7,148,250 - Tsukamoto , et al. December 12, 2 | 2006-12-12 |
| Thiol-based NAALADase inhibitors App 20060135812 - Tsukamoto; Takashi ; et al. | 2006-06-22 |
| Thiol-based NAALADase inhibitors Grant 6,992,215 - Tsukamoto , et al. January 31, 2 | 2006-01-31 |
| Hydroxamic acids and acyl hydroxamines as NAALADase inhibitors App 20060009525 - Tsukamoto; Takashi ; et al. | 2006-01-12 |
| Hydroxamic acids and acyl hydroxamines as naaladase inhibitors Grant 6,884,907 - Tsukamoto , et al. April 26, 2 | 2005-04-26 |
| Thiol-based NAALADase inhibitors App 20050085503 - Tsukamoto, Takashi ; et al. | 2005-04-21 |
| Indoles as naaladase inhibitors App 20050080128 - Tsukamoto, Takashi ; et al. | 2005-04-14 |
| Thiol-based NAALADase inhibitors Grant 6,812,364 - Tsukamoto , et al. November 2, 2 | 2004-11-02 |
| Thiol-based NAALADase inhibitors App 20030216468 - Tsukamoto, Takashi ; et al. | 2003-11-20 |
| Thiol-based NAALADase inhibitors Grant 6,586,623 - Tsukamoto , et al. July 1, 2 | 2003-07-01 |
| Thiol-based NAALADase inhibitors App 20030105088 - Tsukamoto, Takashi ; et al. | 2003-06-05 |
| Hydroxamic acids and acyl hydroxamines as naaladase inhibitors App 20030087897 - Tsukamoto, Takashi ; et al. | 2003-05-08 |
| NAALADase inhibitors useful as pharmaceutical compounds and compositions App 20030083374 - Jackson, Paul F. ; et al. | 2003-05-01 |
| NAALADase inhibitors useful as pharmaceutical compounds and compositions Grant 6,458,775 - Jackson , et al. October 1, 2 | 2002-10-01 |
| Peptidomimetic inhibitors of cathepsin D and plasmepsins I and II Grant 5,849,691 - Majer , et al. December 15, 1 | 1998-12-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 